First human tests: is this new drug safe?
NCT ID NCT06395012
Summary
This early-stage study aimed to check if a new drug called LY3985297 is safe and how the body handles it. It involved 140 healthy volunteers who received either the drug or a placebo as a single shot or several shots over time. The main goal was to watch for side effects and measure how much of the drug gets into the blood and how long it stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel ACT
Anaheim, California, 92801, United States
-
ICON
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.